NATX Plasmids, for: DNA Vaccines, Gene Therapeutics, Viral Vectors andBiophamacueticals

NTC's Molecular Services
Rapid-VACC™ DNA vaccine cloning services

NTC Products and Services

VECTORS
XMammalian Vectors
XAntibiotic-Free Vecotrs
XRig-I Activating Vectors
XpDNAVACCUltra Vector
XLinear Vectors
XRecombineering Vectors
XAutolytic E. coli Cell Lines
XGene Sllencing (transient)
XGene Sllencing (retroviral, stable)

XAnti-Silencing Elements

CELL LINES
XAutolytic E. coli Cell Lines

DNA VACCINES
X
RapidVACC™

RECOMBINANT PROTEINS
X
pVEX™
X
Fluorescent Proteins

PLASMIDS
X
Small Scale Plasmid DNA
X
Small Scale C of A
X
Large Scale Plasmid DNA
X
Large Scale C of A
X
Plasmid DNA Order Form
X
E. coli Cell paste
X
DNA FERMENTATION PROCESS
X
HyperGRO™ Process
X
HyperGRO™ Licensing
X
HyperGRO™ Pricing

PROCESS DEVELOPMENT
X
Process Development Basics
X
Process Licensing


HYPERTAQ™ DNA POLYMERASE

NTC Vector Development ServicesX|XE. coli Strain EngineeringX|XLinearized Cloning VectorsX|XRapid-VACC™ DNA vaccine cloningX|XBiologics Product DevelopmentX|XPlasmid Production

Rapid-VACC™ DNA vaccine cloning services

Rapid-VACC is a cloning service that allows production of new vaccines in a 2-4 week timeframe, in keeping with pandemic response preparedness.  The process incorporates rational design (Williams et al., 2009) and proven DNA vaccine backbones (Williams et al., 2006).

Alternatively, NTC also provides vectors and kits for the construction of DNA vaccines:

Recombineering Vectors: Chromosome Engineering in E. coli

Options include RIG-1 activating eRNA elements:

Rig-1 Activating DNA Vaccine Vectors

And antibiotic-free plasmid DNA backbones with highest copy yielding plasmids (Luke et al., 2009):

Antibiotic-free RNA-OUT Marker for Mammailian Expression andDNA Vaccine Vectors




References:

Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production. Biotechnol. Adv. 27:353-370. Williams, JA, Carnes, AE, Hodgson, CP, (2009)

pDNAVACCultra family: High throughput intracellular targeting DNA vaccine plasmids. Vaccine 24:4671-4679, Williams, JA, Luke, J, Johnson, L, Hodgson, CP (2006)

Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selective system.
Vaccine (2008)Luke, J, Carnes, AE, Hodgson, CP, Williams, JA,








Contact NTC, Toll free: 1-(888) WIZ-BANG

Plasmids, Recombinant Proteins, DNA Vaccines, Viral Vectors, Therapeutic Genes, Fermentation Technology for Gene Therapy and Biotechnology
NTC's free resource "Site" for the biotechnology industry,
including Databases and Sequences Analysis Tool
s



WWW http://www.natx.com